■ Heart failure guidelines: What you need to know about the 2017 focused update

L H Haselhuhn, D J Brotman, I S Wittstein

Cleveland Clinic Journal of Medicine 2019, vol 86 (2): 123-139

https://www.mdedge.com/ccjm/article/193385/cardiology/heart-failure-guidelines-what-you-need-know-about-2017-focused-update

 

■ Exercise training and heart failure: a review of the literature

Card Fail Rev. 2019 Feb; 5(1): 57–61.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396064/

 

■ Current landscape of heart failure gene therapy

Jake M. Kieserman, Valerie D. Myers, Praveen Dubey, Joseph Y. Cheung, Arthur M. Feldman

J Am Heart Assoc. 2019 May 21; 8(10): e012239

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585330/

 

■ A comprehensive review of chronic heart failure pharmacotherapy treatment approaches in African Americans

Frank Tillman, Jennifer Kim, Tanya Makhlouf, Leah Osae

Ther Adv Cardiovasc Dis. 2019; 13: 1753944719840192

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535737/

 

■ Heart failure with preserved ejection fraction in the elderly: pathophysiology, diagnosis and therapeutic approach

Ernesto Ruiz Duque, Alexandros Briasoulis, Paulino A Alvarez

J Geriatr Cardiol. 2019 May; 16(5): 421–428

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558574/

 

■ Self-management of heart failure in dementia and cognitive impairment: a systematic review

Janaka Lovell, Tony Pham, Samer Q. Noaman et al

BMC Cardiovasc Disord. 2019; 19: 99.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489234/

 

■ Telemedicina in heart failure – more than nice to have?

  1. G. M. J. Eurlings, J. J. Boyne, R. A. de Boer, H. P. Brunner-La Rocca

Neth Heart J. 2019 Jan; 27(1): 5–15

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311157/

 

■ The impact of cateter ablation for atrial fibrillation in heart failure

Konstantinos Moschonas, Adam Nabeebaccus, Darlington O. Okonko et al

J Arrhythm. 2019 Feb; 35(1): 33–42

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373662/

 

■ Treating oxidative stress in heart failure: past, presente, and future

A van der Pol, W H van Gilst, A A Voors et al

European Journal of Heart Failure 2019, vol 21 (4): 425-435

https://onlinelibrary.wiley.com/doi/10.1002/ejhf.1320

 

■ Cardiac contratiligy modulation: mechanisms of action in heart failure with reduced ejection fraction and beyond

C Tschöpe, B Kherad, O Klein et al

European Journal of Heart Failure 2019, vol 21 (1): 14-22

https://onlinelibrary.wiley.com/doi/10.1002/ejhf.1349

 

■ Heart failure with preserved ejection fraction, atrial fibrillation, and the role of senile amyloidosis

M P van den Berg, B A Mulder, S H C Klaassen et al

European Heart Journal 2019, vol 40 (16): 1287-1293

https://academic.oup.com/eurheartj/article/40/16/1287/5310346

 

■ Heart failure and problems with frailty syndrome: Why it is time to care about frailty syndrome in heart failure

Izabella Uchmanowicz, Agnieszka Młynarska, Magdalena Lisiak et al

Card Fail Rev. 2019 Feb; 5(1): 37–43

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396065/

 

■ Heart failure and cancer: mechanisms of old and new cardiotoxic drugs in cancer patients

Alessandra Cuomo, Alessio Rodolico, Amalia Galdieri, et al

Card Fail Rev. 2019 May; 5(2): 112–118

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545979/

 

■ Subclinical left ventricular dysfunction during chemotherapy

Martin Nicol, Mathilde Baudet, Alain Cohen-Solal

Card Fail Rev. 2019 Feb; 5(1): 31–36

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396067/

 

■ Prognostic value of right ventricular dysfunction or elevated cardiac biomarker in patients with low-risk pulmonary embolism: a systematic review and meta-analysis

S Barco, S H Mahmoudpour, B Planquette et al

European Heart Journal 2019, vol 40 (11): 902-910

https://academic.oup.com/eurheartj/article/40/11/902/5263773

 

■ Biomarkers of inflammation in left ventricular diastolic dysfunction

Mocan M, Mocan Hognogi LD, Anton FP et al

Dis Markers. 2019 Jun 2;2019:758369

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589287/

 

■ Natriuretic peptides in chronic heart failure

Hans-Peter Brunner-La Rocca, Sandra Sanders-van Wijk

Card Fail Rev. 2019 Feb; 5(1): 44–49

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396059/

 

■ Use of renin-angiotensin-aldosterone system inhibitors in older patients with heart failure and reduced ejection fraction

Davide Stolfo, Gianluigi Savarese

Card Fail Rev. 2019 May; 5(2): 70–73

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545993/

 

■ The limitations of symptoms-based heart failure managementLampros Papadimitriou, Charles K Moore, Javed Butler, Robert C Long

Card Fail Rev. 2019 May; 5(2): 74–77

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546002/

 

■ Aortic stenosis and heart failure: disease ascertainment and statistical considerations for clinical trials

Ernest Spitzer, Rebecca T Hahn, Philippe Pibarot, et a

Card Fail Rev. 2019 May; 5(2): 99–105

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545996/

 

■ The new heart failure association definition of advanced heart failure

Marco Metra, Elisabetta Dinatolo, Nicolò Dasseni

Card Fail Rev. 2019 Feb; 5(1): 5–8

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396060/

 

■  Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Estratificação de Risco Cardiovascular

Novo endereço:

Consultório: Rua Padre Rolim 815/sala 815

Tel: 33245518 (Consulta Particular/Unimed)

– Centro Médico Unimed BH/Contagem/Pedro I

Belo Horizonte/MG/Brasil

CRMMG: 7026

Email: pfleite1873@gmail.com